A detailed history of Reyes Financial Architecture, Inc. transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Reyes Financial Architecture, Inc. holds 633 shares of AIKI stock, worth $2,405. This represents 0.0% of its overall portfolio holdings.

Number of Shares
633
Holding current value
$2,405
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 09, 2025

BUY
N/A
633 New
633 $3.44 Million

Others Institutions Holding AIKI

About AIkido Pharma Inc.


  • Ticker AIKI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,485,100
  • Market Cap $20.8M
  • Description
  • AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...
More about AIKI
Track This Portfolio

Track Reyes Financial Architecture, Inc. Portfolio

Follow Reyes Financial Architecture, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reyes Financial Architecture, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Reyes Financial Architecture, Inc. with notifications on news.